Joseph S. McCracken, Director at LUMOS PHARMA, INC. (LUMO), bought 4,000 shares at $5.03 ($20K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market purchase of $20k LUMO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| LUMO | BUY | 2022-08-26 | $27K | — | Filing → |
| LUMO | BUY | 2021-08-13 | $113K | — | Filing → |
| SVRA | BUY | 2021-03-15 | $200K | — | Filing → |